Abstract:Owa and Owa inquired about the serologic tests of the 3 neonates and the treatment of neonates with COVID-19.The serologic tests for SARS-CoV-2 were not available until the end of February 2020.Currently, only 6 infected neonates have been reported in China.Four mildly infected neonates improved with primary care.Of 2 critical cases in China, 1 was the third patient in our article, and another neonate with congenital heart disease (6.9-mm atrial septal defect) presented with pneumonia and cardiac insufficiency.The neonate improved rapidly with antibiotics, inotropic therapy, and fluid management.None of the infected neonates received antiviral therapy.Verd et al raised the issue of whether mothers with COVID-19 should continue breastfeeding.Viral nucleic acid for SARS-CoV-2 has not been detected in breast milk thus far.However, the neonates born to an affected mother are at great risk of COVID-19 owing to close contact and should be separated from mothers and fed by formula initially.As our protocol suggested, the isolated mothers should keep pumping to maintain breast milk. 3 Considering the virus may be excreted into the milk during the incubation period, donor milk and breast milk can be considered for use after being screened for SARS-CoV-2. 3 Mimouni et al questioned the criteria used to diagnose COVID-19 pneumonia.In our study, 3 neonates with COVID-19 had not been reported in other cohorts before publication.Patients 1 and 2 were born February 3, 2020, and February 5, 2020, respectively.Patient 1 was admitted to the neonatal intensive care unit owing to lethargy and fever (37.6 °C) at day 3 of life (February 5, 2020).His procalcitonin level (PCT) was 0.090 ng/mL (normal range, ≤0.05 ng/mL).Patient 2 experienced lethargy, vomiting, and fever (37.7 °C), and laboratory test results showed leukocytosis, lymphocytopenia, and an elevated creatine kinase myocardial band.Although no respiratory symptoms were observed and chest images showed infiltrates, the 2 neonates were diagnosed as having symptomatic neonatal COVID-19 based on the exposure history and positive SARS-CoV-2 test result. 3,4 Currently, less than 10 confirmed neonatal cases have been reported.Therefore, the full clinical picture of neonatal COVID-19 remains uncertain.Hijikata et al, Abu Raya et al, and Vecchio pointed out that the serial serologic tests were helpful to diagnose congenital COVID-19.We do agree that viral or serologic test results cannot confirm the intrauterine SARS-CoV-2 infection.However, at the early phase of the COVID-19 epidemic in China, the testing methods for SARS-CoV-2 were limited.Initially, real-time fluorescence PCR was only available for SARS-CoV-2 using nasopharyngeal and oropharyngeal specimens.At present, both serological testing and RT-PCR can be performed; yet, no more neonates with early-onset COVID-19 have been identified with the control of the COVID-19 epidemic in China.We are concerned about the neurologic outcomes of neonates with COVID-19 or born to infected mothers.The study from Zhu et al 5 has shown that 2 newborns presented with elevated PCT levels and interleukin 6 with 72 hours of life (interleukin 6, 274.6 pg/mL and PCT, 9.2 ng/mL in newborn 3; and PCT, 20.74 pg/mL in newborn 4); 1 died of multiple organ failure.These elevated inflammatory markers may be associated with the maternal COVID-19.Therefore, the infants with COVID-19 or born to affected mothers have been followed up in our clinic.

Immunophenotypes of Newborns From SARS-CoV-2-infected Mothers

SARS-CoV2 Infection During Pregnancy Causes Persistent Immune Abnormalities in Women Without Affecting the Newborns

Single-cell immunophenotyping of the fetal immune response to maternal SARS-CoV-2 infection in late gestation

Neonatal SARS-CoV-2 immunoglobulin G antibodies at delivery and their impact on COVID-19

Genital Dysbiosis and Different Systemic Immune Responses Based on the Trimester of Pregnancy in SARS-CoV-2 Infection

Immune Response and Transplacental Antibody Transfer in Pregnant Women after COVID-19 Vaccination

COVID-Vaccines in Pregnancy: Maternal and Neonatal Response over the First 9 Months after Delivery

Error in the Abstract and Results Section

Maternal-infant transfer of SARS-CoV-2 antibodies following vaccination in pregnancy: A prospective cohort study

Association of maternal infection of SARS-CoV-2 and neonatal susceptibility: A retrospective cohort study

Peripartum outcomes and immune responses after SARS-CoV-2 infection in the third trimester of pregnancy

Immune and Pathophysiologic Profiling of Antenatal COVID-19 in the GIFT Cohort: A Singaporean Case-Control Study

#49: Management and Outcomes of Infants Born to Mothers with SARS-CoV-2 Infection in Pregnancy

Transmitted Fetal Immune Response in Cases of SARS-CoV-2 Infections during Pregnancy

Analysis of the transplacental transmission of SARS CoV-2 virus and antibody transfer according to the gestational age at maternal infection

Prevalence of SARS-CoV-2 in newborns born to SARS-CoV-2-positive mothers at 2 weeks of life

Mild/asymptomatic COVID-19 in unvaccinated pregnant mothers impairs neonatal immune responses

Deep immune profiling of the maternal-fetal interface with mild SARS-CoV-2 infection

Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies among parturient women treated with BNT162b2 messenger RNA vaccine during pregnancy

SARS-CoV-2 anti-RBD and anti-N protein responses are differentially regulated between mother-child pairs: insight from a national study cohort at the Faroe Islands

Comparison of Maternal and Neonatal Antibody Levels After COVID-19 Vaccination vs SARS-CoV-2 Infection